68 articles
This post explores how drug manufacturers leverage secondary patents to manage the patent cliff and maintain exclusivity. A detailed analysis of Entresto’s patent timeline and Indian legal context…
This post analyses recent Indian patent cases from 2022, focusing on notable court decisions such as MSN Laboratories v. Novartis Ag. It provides legal insights into patent infringement…
This post analyses major Indian patent case laws from 2021, with a focus on Delhi High Court decisions involving interim injunctions and pharmaceutical patents. It offers an objective…
This article examines recent patent litigation before the Delhi High Court, highlighting cases involving Novartis and Sulphur Mills in 2021. It discusses key judicial findings on patent validity,…
This article summarises pivotal Delhi High Court decisions on patent disputes in 2021, particularly involving pharmaceutical products. The analysis covers interim injunctions and key arguments in Indian patent…
The H. Lundbeck A/S vs Symed Labs Limited case involved a pre-notice settlement of a patent dispute, with the Delhi High Court decreeing the suit on agreed terms.…
The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global…
A detailed review of major Indian patent cases and judgments from 2020, addressing core issues in patent opposition, litigation, and enforcement. The analysis offers insights into judicial trends…
Mr. Gaurav Mishra presented an in-depth session on compulsory licensing in India under the Patents Act at a DST Rajasthan event. The talk covered legal provisions, case studies,…
This bulletin provides updates on the COVID-19 patent pool, opposition from leading pharmaceutical companies, and key patent law changes in India and abroad. It includes IPO e-filing developments,…